RESULTS : Among 4590 pregnant and postpartum patients with AIS , 180 ( 0.039 ) were treated with MT , and rates of utilization increased following the MT clinical trial era ( 2015 - 2018 ; 0.019 versus 0.053 , P = 0.011 ) .